BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35524581)

  • 1. Hepatic MDM2 Causes Metabolic Associated Fatty Liver Disease by Blocking Triglyceride-VLDL Secretion via ApoB Degradation.
    Lin H; Wang L; Liu Z; Long K; Kong M; Ye D; Chen X; Wang K; Wu KK; Fan M; Song E; Wang C; Hoo RL; Hui X; Hallenborg P; Piao H; Xu A; Cheng KK
    Adv Sci (Weinh); 2022 Jul; 9(20):e2200742. PubMed ID: 35524581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LZP is required for hepatic triacylglycerol transportation through maintaining apolipoprotein B stability.
    Wu JX; He KY; Zhang ZZ; Qu YL; Su XB; Shi Y; Wang N; Wang L; Han ZG
    PLoS Genet; 2021 Feb; 17(2):e1009357. PubMed ID: 33591966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very Low Density Lipoprotein Assembly Is Required for cAMP-responsive Element-binding Protein H Processing and Hepatic Apolipoprotein A-IV Expression.
    Cheng D; Xu X; Simon T; Boudyguina E; Deng Z; VerHague M; Lee AH; Shelness GS; Weinberg RB; Parks JS
    J Biol Chem; 2016 Nov; 291(45):23793-23803. PubMed ID: 27655915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD/NASH development.
    Yang M; Liu Q; Huang T; Tan W; Qu L; Chen T; Pan H; Chen L; Liu J; Wong CW; Lu WW; Guan M
    Theranostics; 2020; 10(24):10874-10891. PubMed ID: 33042259
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.
    Riches FM; Watts GF; Naoumova RP; Kelly JM; Croft KD; Thompson GR
    Int J Obes Relat Metab Disord; 1998 May; 22(5):414-23. PubMed ID: 9622338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion.
    VerHague MA; Cheng D; Weinberg RB; Shelness GS
    Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2501-8. PubMed ID: 24030551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CREBH mediates metabolic inflammation to hepatic VLDL overproduction and hyperlipoproteinemia.
    Song Y; Zhao M; Cheng X; Shen J; Khound R; Zhang K; Su Q
    J Mol Med (Berl); 2017 Aug; 95(8):839-849. PubMed ID: 28455595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory effects of arachidonate 5-lipoxygenase on hepatic microsomal TG transfer protein activity and VLDL-triglyceride and apoB secretion in obese mice.
    López-Parra M; Titos E; Horrillo R; Ferré N; González-Périz A; Martínez-Clemente M; Planagumà A; Masferrer J; Arroyo V; Clària J
    J Lipid Res; 2008 Dec; 49(12):2513-23. PubMed ID: 18645210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in fatty acid metabolism in rat hepatocytes in response to dietary n-3 fatty acids are associated with changes in the intracellular metabolism and secretion of apolipoprotein B-48.
    Brown AM; Baker PW; Gibbons GF
    J Lipid Res; 1997 Mar; 38(3):469-81. PubMed ID: 9101428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut inflammation exacerbates high-fat diet induced steatosis by suppressing VLDL-TG secretion through HNF4α pathway.
    Li P; Chen X; Dong M; Luo J; Lu S; Chen M; Zhang Y; Zhou H; Jiang H
    Free Radic Biol Med; 2021 Aug; 172():459-469. PubMed ID: 34186207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease.
    Fabbrini E; Mohammed BS; Korenblat KM; Magkos F; McCrea J; Patterson BW; Klein S
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2727-35. PubMed ID: 20371660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B.
    Tietge UJ; Bakillah A; Maugeais C; Tsukamoto K; Hussain M; Rader DJ
    J Lipid Res; 1999 Nov; 40(11):2134-9. PubMed ID: 10553017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of fish oil diet on hepatic lipid metabolism in nonhuman primates: lowering of secretion of hepatic triglyceride but not apoB.
    Parks JS; Johnson FL; Wilson MD; Rudel LL
    J Lipid Res; 1990 Mar; 31(3):455-66. PubMed ID: 2341808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model.
    Taghibiglou C; Carpentier A; Van Iderstine SC; Chen B; Rudy D; Aiton A; Lewis GF; Adeli K
    J Biol Chem; 2000 Mar; 275(12):8416-25. PubMed ID: 10722675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mice expressing only the mutant APOE3Leiden gene show impaired VLDL secretion.
    Mensenkamp AR; Teusink B; Baller JF; Wolters H; Havinga R; van Dijk KW; Havekes LM; Kuipers F
    Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1366-72. PubMed ID: 11498467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditional hepatocyte ablation of PDIA1 uncovers indispensable roles in both APOB and MTTP folding to support VLDL secretion.
    Chen Z; Wang S; Pottekat A; Duffey A; Jang I; Chang BH; Cho J; Finck BN; Davidson NO; Kaufman RJ
    Mol Metab; 2024 Feb; 80():101874. PubMed ID: 38211723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of n-3 fatty acids in the diets of rats or directly to hepatocyte cultures results in different effects on hepatocellular ApoB metabolism and secretion.
    Brown AM; Castle J; Hebbachi AM; Gibbons GF
    Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):106-14. PubMed ID: 9888872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride-rich lipoprotein metabolism.
    Deprince A; Hennuyer N; Kooijman S; Pronk ACM; Baugé E; Lienard V; Verrijken A; Dirinck E; Vonghia L; Woitrain E; Kloosterhuis NJ; Marez E; Jacquemain P; Wolters JC; Lalloyer F; Eberlé D; Quemener S; Vallez E; Tailleux A; Kouach M; Goossens JF; Raverdy V; Derudas B; Kuivenhoven JA; Croyal M; van de Sluis B; Francque S; Pattou F; Rensen PCN; Staels B; Haas JT
    Hepatology; 2023 Apr; 77(4):1287-1302. PubMed ID: 35735979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic ABCA1 deficiency is associated with delayed apolipoprotein B secretory trafficking and augmented VLDL triglyceride secretion.
    Liu M; Chung S; Shelness GS; Parks JS
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Oct; 1862(10 Pt A):1035-1043. PubMed ID: 28694219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.